- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Insider-Bought Value Plays
Hong Kong Pharmaceuticals & Biotech Insider-Bought Value Plays
Results
7
7 companies
Consun Pharmaceutical Group
Market Cap: HK$10.8b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$12.87
7D
-3.4%
1Y
12.9%
CanSino Biologics
Market Cap: HK$9.4b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$21.34
7D
-4.9%
1Y
-38.1%
InnoCare Pharma
Market Cap: HK$23.4b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$10.78
7D
-0.6%
1Y
-19.4%
China Medical System Holdings
Market Cap: HK$24.5b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$10.12
7D
-2.7%
1Y
-15.5%
JBM (Healthcare)
Market Cap: HK$1.6b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$1.93
7D
-15.7%
1Y
-36.7%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.3b
Manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People’s Republic of China.
8049
HK$2.40
7D
-10.4%
1Y
11.6%
Pak Fah Yeow International
Market Cap: HK$741.7m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.38
7D
0.8%
1Y
-3.6%